Related Experiment Videos
Future directions in the management of soft tissue sarcomas
1Division of Clinical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115.
Hematological Oncology
|January 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Treatment Efficacy Score-continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours.
European journal of cancer (Oxford, England : 1990)·2013
The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2002
Epigenetic Rewiring and Context-Dependent Therapeutic Vulnerabilities in Myeloproliferative Neoplasms.
Hematological oncology·2026
Venetoclax in Combination With Chemo-Immunotherapy in Richter Transformation: A Real-Life Experience.
Hematological oncology·2026
Langerhans Cell Histiocytosis in Adults: A Canadian Multicenter Case Series.
Hematological oncology·2026
A marine-derived meroterpenoid inhibits colorectal cancer via PI3K pathway modulation in mice.
Marine life science & technology·2026
SGLT2 inhibitor therapy is associated with IL-10/TGF-α/sVEGFR3 signalling and adipose tissue remodelling in advanced heart failure.
Journal of molecular and cellular cardiology plus·2026